Pfizer To Acquire Icagen

20 Jul 2011
Pfizer Inc. and Icagen, Inc. have entered into a definitive merger agreement. Pfizer, which currently owns approximately 11% of Icagen's fully diluted shares, will acquire the remaining 8.3 million shares at a price of $6.00 per share.